Rachel McMinn
Chief Executive Officer, Director · Neurogene Inc.
- 2024
- Oct 2, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Rachel McMinn files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christine Mikail Cvijic - $900K in NGNE purchases and sales in the last 12 months
- Stuart Cobb - $141K in NGNE purchases and sales in the last 12 months
- Julie Jordan - $18K in NGNE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Rachel McMinn?
Rachel McMinn is a corporate insider, tracked as Chief Executive Officer, Director of Neurogene Inc. (NGNE). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Rachel McMinn submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Rachel McMinn been buying or selling stock?
Recorded transactions: 1 open-market purchase ($969K) and 1 open-market sale ($74K) across all tracked filings.
